Salvage thoracoscopic resection after nivolumab for stage IV-Reference-Cited by-同舟云学术

Salvage thoracoscopic resection after nivolumab for stage IV

Published:2020-04-10 Issue:4 Volume:28 Page:216-218
ISSN:0218-4923
Container-title:Asian Cardiovascular and Thoracic Annals
language:en
Short-container-title:Asian Cardiovasc Thorac Ann

Author:

Hamaji Masatsugu¹^ORCID,Ozasa Hiroaki²,Yoshizawa Akihiko³,Date Hiroshi¹

Affiliation:

1. Department of Thoracic Surgery, Kyoto University, Kyoto, Japan

2. Department of Pulmonary Medicine, Kyoto University, Kyoto, Japan

3. Department of Diagnostic Pathology, Kyoto University, Kyoto, Japan

Abstract

There are limited data on the surgical management of localized and residual diseases in patients with stage IV non-small-cell lung cancer that was treated with nivolumab. Herein, we present two patients who underwent salvage thoracoscopic resection for residual diseases (left lower lobectomy and paratracheal lymph node resection, respectively) after chemotherapy and immunotherapy for stage IV adenocarcinoma. The indications, intraoperative findings, and histopathological findings are discussed in this report.

Publisher

SAGE Publications

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,General Medicine,Surgery

Link

http://journals.sagepub.com/doi/pdf/10.1177/0218492320919477

Reference5 articles.

1. Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer

2. First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer

3. Neoadjuvant PD-1 Blockade in Resectable Lung Cancer

4. Initial Experience With Lung Cancer Resection After Treatment With T-Cell Checkpoint Inhibitors

5. Correlation between immune-related adverse events and efficacy in non-small cell lung cancer treated with nivolumab

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Salvage Surgery After Immune Checkpoint Inhibitors for Advanced Non-Small Cell Lung Cancer: Potential Association Between Immune-Related Adverse Events and Longer Survival;Clinical Lung Cancer;2022-07

2. Salvage pulmonary resection in stages IIIb–IV lung cancer after treatment with immune checkpoint inhibitors case series and literature review;Journal of Surgical Oncology;2021-09-27